Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Human immunodeficiency virus 1 | Aberrant vpr protein | Starlite/ChEMBL | No references |
Homo sapiens | tumor protein p53 | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Equus caballus | Ferritin light chain | Starlite/ChEMBL | No references |
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Homo sapiens | apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3D | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus granulosus | tumor protein p63 | Get druggable targets OG5_140038 | All targets in OG5_140038 |
Echinococcus multilocularis | tumor protein p63 | Get druggable targets OG5_140038 | All targets in OG5_140038 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | apoferritin-2 | Ferritin light chain | 175 aa | 142 aa | 29.6 % |
Echinococcus multilocularis | expressed protein | Ferritin light chain | 175 aa | 146 aa | 30.1 % |
Schistosoma mansoni | apoferritin-2 | Ferritin light chain | 175 aa | 146 aa | 28.8 % |
Schistosoma mansoni | ferritin | Ferritin light chain | 175 aa | 171 aa | 44.4 % |
Schistosoma japonicum | Ferritin, putative | Ferritin light chain | 175 aa | 144 aa | 24.3 % |
Echinococcus granulosus | expressed protein | Ferritin light chain | 175 aa | 146 aa | 28.8 % |
Schistosoma mansoni | ferritin | Ferritin light chain | 175 aa | 171 aa | 43.9 % |
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | hexokinase, putative | 0.0671 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0123 | 0.1021 | 0.1021 |
Trypanosoma brucei | hexokinase, putative | 0.0671 | 1 | 0.5 |
Loa Loa (eye worm) | hexokinase type II | 0.0671 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0213 | 0.2507 | 0.2507 |
Onchocerca volvulus | 0.0671 | 1 | 1 | |
Brugia malayi | hexokinase type II | 0.0213 | 0.2507 | 0.2507 |
Echinococcus multilocularis | hexokinase type 2 | 0.0671 | 1 | 1 |
Echinococcus multilocularis | tumor protein p63 | 0.0408 | 0.5695 | 0.5206 |
Echinococcus multilocularis | hexokinase | 0.0671 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0182 | 0.2002 | 0.2002 |
Loa Loa (eye worm) | hexokinase | 0.0208 | 0.2414 | 0.2414 |
Leishmania major | hexokinase, putative | 0.0671 | 1 | 0.5 |
Brugia malayi | Hexokinase family protein | 0.0208 | 0.2414 | 0.2414 |
Loa Loa (eye worm) | hypothetical protein | 0.0182 | 0.2002 | 0.2002 |
Plasmodium vivax | hexokinase, putative | 0.0671 | 1 | 0.5 |
Loa Loa (eye worm) | nicotinic acetylcholine receptor alpha subunit | 0.0123 | 0.1021 | 0.1021 |
Plasmodium falciparum | hexokinase | 0.0671 | 1 | 0.5 |
Trypanosoma cruzi | hexokinase, putative | 0.0671 | 1 | 0.5 |
Brugia malayi | Hexokinase family protein | 0.0671 | 1 | 1 |
Onchocerca volvulus | Hexokinase homolog | 0.0421 | 0.5906 | 0.5441 |
Echinococcus multilocularis | geminin | 0.0205 | 0.2365 | 0.1496 |
Onchocerca volvulus | 0.0671 | 1 | 1 | |
Echinococcus granulosus | hexokinase | 0.0671 | 1 | 1 |
Echinococcus granulosus | tumor protein p63 | 0.0408 | 0.5695 | 0.5206 |
Echinococcus granulosus | hexokinase | 0.0671 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0213 | 0.2507 | 0.2507 |
Onchocerca volvulus | 0.0421 | 0.5906 | 0.5441 | |
Brugia malayi | Hexokinase family protein | 0.0421 | 0.5906 | 0.5906 |
Onchocerca volvulus | 0.0671 | 1 | 1 | |
Echinococcus multilocularis | hexokinase | 0.0671 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0123 | 0.1021 | 0.1021 |
Entamoeba histolytica | hexokinase 1 | 0.0671 | 1 | 0.5 |
Onchocerca volvulus | 0.0182 | 0.2002 | 0.1092 | |
Loa Loa (eye worm) | hypothetical protein | 0.0458 | 0.6507 | 0.6507 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.2365 | 0.1496 |
Echinococcus granulosus | hexokinase | 0.0671 | 1 | 1 |
Brugia malayi | nicotinic acetylcholine receptor alpha subunit, putative | 0.0123 | 0.1021 | 0.1021 |
Loa Loa (eye worm) | hexokinase | 0.0671 | 1 | 1 |
Treponema pallidum | hexokinase (hxk) | 0.0671 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0123 | 0.1021 | 0.1021 |
Brugia malayi | Cation transporter family protein | 0.0123 | 0.1021 | 0.1021 |
Loa Loa (eye worm) | hexokinase | 0.0421 | 0.5906 | 0.5906 |
Echinococcus granulosus | hexokinase type 2 | 0.0671 | 1 | 1 |
Echinococcus multilocularis | hexokinase | 0.0671 | 1 | 1 |
Entamoeba histolytica | hexokinase 2 | 0.0671 | 1 | 0.5 |
Leishmania major | hexokinase, putative | 0.0671 | 1 | 0.5 |
Loa Loa (eye worm) | hexokinase | 0.0671 | 1 | 1 |
Toxoplasma gondii | hexokinase | 0.0671 | 1 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.2365 | 0.1496 |
Schistosoma mansoni | hexokinase | 0.0671 | 1 | 1 |
Trypanosoma brucei | hexokinase | 0.0671 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0098 | 0.0612 | 0.0612 |
Echinococcus granulosus | geminin | 0.0205 | 0.2365 | 0.1496 |
Trypanosoma brucei | hexokinase | 0.0671 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Max_Activity_Concent (functional) | 6 uM | PubChem BioAssay. Thermal shift assay to identify compound binding to Kelch domain of Keap1 protein Measured in Biochemical System Using RT-PCR - 2119-02_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 0.5623 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Vif-A3F Interactions: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | = 0.8913 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | 1.9953 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 2.9093 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 4.6109 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PUBCHEM_BIOASSAY: qHTS assay for re-activators of p53 using a Luc reporter. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504709] | ChEMBL. | No reference |
Potency (functional) | 12.5893 uM | PubChem BioAssay. qHTS Assay for Inhibitors of the HIV-1 protein Vpr. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 21.1923 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 25.1189 uM | PubChem BioAssay. Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PUBCHEM_BIOASSAY: qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771] | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID540262] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.